Another known NF-κB inhibitor is dimethylamino parthenolide (DMAPT), which induces the expression of two methyltransferases, i.e., SETD2 and NSD1; the latter is epigenetically silenced in neuroblastoma and functions therefore as a tumor suppressor [62]. Here, NFKB1 is linked to neoplasm.